60 DEGREES PHARMACEUTICALS, INC. (SXTP) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 19 transactions totaling $114.3K, demonstrating a bullish sentiment with $114.3K in net insider flow. The most recent transaction on Dec 15, 2025 involved a purchase of 9,670 shares valued at $7.7K.
No significant insider buying has been recorded for SXTP in the recent period.
No significant insider selling has been recorded for SXTP in the recent period.
Based on recent SEC filings, insider sentiment for SXTP is bullish with an Insider Alignment Score of 100/100 and a net flow of $114.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at 60 DEGREES PHARMACEUTICALS, INC. (SXTP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading SXTP stock, having executed 19 transactions in the past 90 days. The most active insider is Therapeutics International Sa Knight (Executive), who has made 2 transactions totaling $216.4K.
Get notified when executives and directors at SXTP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | S. Dow Geoffrey | Executive | Purchase | 9,670 | $0.80 | $7.7K | |
| Dec 11, 2025 | S. Dow Geoffrey | Executive | Purchase | 3,613 | $0.92 | $3.3K | |
| Dec 10, 2025 | S. Dow Geoffrey | Executive | Purchase | 9,350 | $0.95 | $8.9K | |
| Sep 12, 2025 | S. Dow Geoffrey | Executive | Award | 7,201 | $1.39 | $10.0K | |
| Jan 17, 2025 | Landon Kristen | Executive | Award | 4,540 | $N/A | $0 | |
| Aug 27, 2024 | Xu Cheryl | Executive | Purchase | 5,000 | $1.70 | $8.5K | |
| May 16, 2024 | W. Allen Charles | Executive | Option Exercise | 4,000 | $0.22 | $880 | |
| May 16, 2024 | S. Dow Geoffrey | Executive | Option Exercise | 17,000 | $0.22 | $3.7K | |
| May 16, 2024 | Field Paul | Executive | Option Exercise | 4,000 | $0.22 | $880 | |
| May 16, 2024 | Miller Tyrone | Executive | Award | 15,000 | $0.22 | $3.3K | |
| May 16, 2024 | Toovey Stephen | Executive | Award | 4,000 | $0.22 | $880 | |
| May 16, 2024 | Xu Cheryl | Executive | Option Exercise | 2,000 | $0.22 | $440 | |
| Apr 12, 2024 | S. Dow Geoffrey | Executive | Option Exercise | 68,000 | $0.27 | $18.4K | |
| Apr 12, 2024 | Miller Tyrone | Executive | Award | 60,000 | $0.27 | $16.2K | |
| Feb 1, 2024 | Xu Cheryl | Executive | Option Exercise | 2,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 2 | $216.4K | 56.2% |
Purchase(P) | 6 | $114.3K | 29.7% |
Award(A) | 5 | $30.4K | 7.9% |
Exercise(M) | 6 | $24.3K | 6.3% |
Insiders at 60 DEGREES PHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 8 insiders making 19 transactions totaling $114.3K in purchases versus $0 in sales, the net buying activity of $114.3K signals strong executive confidence. Therapeutics International Sa Knight (Executive) leads the buying activity with $216.4K in transactions across all time.